Neil Cashman insider trades
Open-market stock purchases and sales by Neil Cashman, Chief Scientific Officer at ProMIS Neurosciences Inc, from SEC Form 4 filings since Aug 23, 2023.
Companies traded
- PMN ProMIS Neurosciences Inc: 1 buy, last May 20, 2026